These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1690003)

  • 1. Endoribonucleolytic cleavage of RNA: oligodeoxynucleotide hybrids by the ribonuclease H activity of HIV-1 reverse transcriptase.
    Dudding LR; Harington A; Mizrahi V
    Biochem Biophys Res Commun; 1990 Feb; 167(1):244-50. PubMed ID: 1690003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the ribonuclease H activity of HIV-1 reverse transcriptase using RNA.DNA hybrid substrates derived from the gag region of HIV-1.
    Mizrahi V
    Biochemistry; 1989 Nov; 28(23):9088-94. PubMed ID: 2481501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids.
    Wöhrl BM; Moelling K
    Biochemistry; 1990 Nov; 29(44):10141-7. PubMed ID: 1703002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
    Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities.
    Wöhrl BM; Volkmann S; Moelling K
    J Mol Biol; 1991 Aug; 220(3):801-18. PubMed ID: 1714505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.
    Bordier B; Hélène C; Barr PJ; Litvak S; Sarih-Cottin L
    Nucleic Acids Res; 1992 Nov; 20(22):5999-6006. PubMed ID: 1281317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the RNA- and DNA-dependent DNA polymerase activities of point mutants of HIV-1 reverse transcriptase lacking ribonuclease H activity.
    Dudding LR; Nkabinde NC; Mizrahi V
    Biochemistry; 1991 Oct; 30(43):10498-506. PubMed ID: 1718422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
    Ben-Artzi H; Zeelon E; Gorecki M; Panet A
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
    Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase.
    Mizrahi V; Usdin MT; Harington A; Dudding LR
    Nucleic Acids Res; 1990 Sep; 18(18):5359-63. PubMed ID: 1699202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity.
    Schatz O; Mous J; Le Grice SF
    EMBO J; 1990 Apr; 9(4):1171-6. PubMed ID: 1691093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When retroviral reverse transcriptases reach the end of their RNA templates.
    Fu TB; Taylor J
    J Virol; 1992 Jul; 66(7):4271-8. PubMed ID: 1376369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNase D, a reported new activity associated with HIV-1 reverse transcriptase, displays the same cleavage specificity as Escherichia coli RNase III.
    Hostomsky Z; Hudson GO; Rahmati S; Hostomska Z
    Nucleic Acids Res; 1992 Nov; 20(21):5819-24. PubMed ID: 1280810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of reverse transcriptase and RNase H during HIV-1 replication.
    Wöhrl BM; Moelling K
    Behring Inst Mitt; 1991 Jul; (89):100-7. PubMed ID: 1718256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
    Veal GJ; Agrawal S; Byrn RA
    Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
    Boulme F; Perälä-Heape M; Sarih-Cottin L; Litvak S
    Biochim Biophys Acta; 1997 Apr; 1351(3):249-55. PubMed ID: 9130587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
    Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant HIV-1 reverse transcriptase: purification, primary structure, and polymerase/ribonuclease H activities.
    Mizrahi V; Lazarus GM; Miles LM; Meyers CA; Debouck C
    Arch Biochem Biophys; 1989 Sep; 273(2):347-58. PubMed ID: 2476069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of the HIV-1 p66 reverse transcriptase/RNase H by the p9 protease in vitro generates active p15 RNase H.
    Schulze T; Nawrath M; Moelling K
    Arch Virol; 1991; 118(3-4):179-88. PubMed ID: 1712581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.
    Hostomsky Z; Hostomska Z; Hudson GO; Moomaw EW; Nodes BR
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1148-52. PubMed ID: 1705027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.